ITU Unit Action

TULVEGIO RIVOCERANIB

Elevar Therapeutics, Inc.

ITU Unit Action

Trademark Snap Shot ITU Unit Action (Table presents the data on ITU Unit Action)
OVERVIEW
SERIAL NUMBER	88620374	FILING DATE	09/17/2019
REG NUMBER	0000000	REG DATE	N/A
REGISTER	PRINCIPAL	MARK TYPE	TRADEMARK
INTL REG #	N/A	INTL REG DATE	N/A
TM ATTORNEY	GARDNER, DAWNA BERYL	L.O. ASSIGNED	O30-NOT FOUND

PUB INFORMATION
RUN DATE	08/03/2022
PUB DATE	06/22/2021
STATUS	731-SECOND EXTENSION - GRANTED
STATUS DATE	08/01/2022
LITERAL MARK ELEMENT	TULVEGIO RIVOCERANIB

DATE ABANDONED	N/A	DATE CANCELLED	N/A
SECTION 2F	NO	SECTION 2F IN PART	NO
SECTION 8	NO	SECTION 8 IN PART	NO
SECTION 15	NO	REPUB 12C	N/A
RENEWAL FILED	NO	RENEWAL DATE	N/A
DATE AMEND REG	N/A

FILING BASIS
FILED BASIS		CURRENT BASIS		AMENDED BASIS
1 (a)	NO	1 (a)	NO	1 (a)	NO
1 (b)	YES	1 (b)	YES	1 (b)	YES
44D	NO	44D	NO	44D	NO
44E	NO	44E	NO	44E	NO
66A	NO	66A	NO
NO BASIS	NO	NO BASIS	NO

MARK DATA
STANDARD CHARACTER MARK	NO
LITERAL MARK ELEMENT	TULVEGIO RIVOCERANIB
MARK DRAWING CODE	3-AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/LETTER(S)/NUMBER(S)
COLOR DRAWING FLAG	NO

CURRENT OWNER INFORMATION
PARTY TYPE	20-OWNER AT PUBLICATION
NAME	Elevar Therapeutics, Inc.
ADDRESS	2825 East Cottonwood Parkway, Suite 180 Salt Lake City, UT 84121
ENTITY	03-CORPORATION
CITIZENSHIP	Utah
DBA/AKA	FORMERLY formerly LSK BioPartners, Inc.

GOODS AND SERVICES
INTERNATIONAL CLASS	005
DESCRIPTION TEXT	Pharmaceutical preparations and substances containing rivoceranib for the treatment of cancer

INTERNATIONAL CLASS	035
DESCRIPTION TEXT	Marketing in the field of cancer treatments containing rivoceranib

INTERNATIONAL CLASS	042
DESCRIPTION TEXT	Development of therapeutics for the treatment of cancer containing rivoceranib

GOODS AND SERVICES CLASSIFICATION
INTERNATIONAL CLASS	005	FIRST USE DATE	NONE	FIRST USE IN COMMERCE DATE	NONE	CLASS STATUS	6-ACTIVE

INTERNATIONAL CLASS	035	FIRST USE DATE	NONE	FIRST USE IN COMMERCE DATE	NONE	CLASS STATUS	6-ACTIVE

INTERNATIONAL CLASS	042	FIRST USE DATE	NONE	FIRST USE IN COMMERCE DATE	NONE	CLASS STATUS	6-ACTIVE

MISCELLANEOUS INFORMATION/STATEMENTS
CHANGE IN REGISTRATION	NO
COLORS CLAIMED STATEMENT	Color is not claimed as a feature of the mark.
DISCLAIMER W/PREDETER TXT	"RIVOCERANIB"
DESCRIPTION OF MARK	The mark consists of the stylized upper-case wording "TULVEGIO" above the stylized lowercase wording "RIVOCERANIB". To the left of the letter "T" is the stylized design of a hand tilted toward the letter "T".
TRANSLATION	The wording "TULVEGIO RIVOCERANIB" has no meaning in a foreign language.

PROSECUTION HISTORY
DATE	ENT CD	ENT TYPE	DESCRIPTION	ENT NUM
08/03/2022	EXRA	E	NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	048
08/01/2022	EX2G	S	SOU EXTENSION 2 GRANTED	047
08/01/2022	EXT2	S	SOU EXTENSION 2 FILED	046
08/01/2022	EEXT	I	TEAS EXTENSION RECEIVED	045
06/08/2022	CHAN	I	APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED	044
06/08/2022	TCCA	I	TEAS CHANGE OF CORRESPONDENCE RECEIVED	043
06/08/2022	ARAA	I	ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED	042
06/08/2022	REAP	I	TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED	041
06/08/2022	COAR	I	TEAS CHANGE OF OWNER ADDRESS RECEIVED	040
02/19/2022	EXRA	E	NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	039
02/17/2022	EX1G	S	SOU EXTENSION 1 GRANTED	038
02/17/2022	EXT1	S	SOU EXTENSION 1 FILED	037
02/17/2022	EEXT	I	TEAS EXTENSION RECEIVED	036
08/17/2021	NOAM	E	NOA E-MAILED - SOU REQUIRED FROM APPLICANT	035
06/22/2021	NPUB	E	OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED	034
06/22/2021	PUBO	A	PUBLISHED FOR OPPOSITION	033
06/02/2021	NONP	E	NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED	032
05/19/2021	CNSA	P	APPROVED FOR PUB - PRINCIPAL REGISTER	031
05/19/2021	XAEC	I	EXAMINER'S AMENDMENT ENTERED	030
05/19/2021	GNEN	O	NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED	029
05/19/2021	GNEA	O	EXAMINERS AMENDMENT E-MAILED	028
05/19/2021	CNEA	R	EXAMINERS AMENDMENT -WRITTEN	027
05/19/2021	TEME	I	TEAS/EMAIL CORRESPONDENCE ENTERED	026
05/19/2021	CRFA	I	CORRESPONDENCE RECEIVED IN LAW OFFICE	025
05/17/2021	ALIE	A	ASSIGNED TO LIE	024
02/09/2021	TROA	I	TEAS RESPONSE TO OFFICE ACTION RECEIVED	023
01/08/2021	GNRN	O	NOTIFICATION OF NON-FINAL ACTION E-MAILED	022
01/08/2021	GNRT	O	NON-FINAL ACTION E-MAILED	021
01/08/2021	CNRT	R	NON-FINAL ACTION WRITTEN	020
01/04/2021	ZZZX	Z	PREVIOUS ALLOWANCE COUNT WITHDRAWN	019
12/29/2020	PBCR	Z	WITHDRAWN FROM PUB - OG REVIEW QUERY	018
12/15/2020	CNSA	P	APPROVED FOR PUB - PRINCIPAL REGISTER	017
12/14/2020	TEME	I	TEAS/EMAIL CORRESPONDENCE ENTERED	016
12/14/2020	CRFA	I	CORRESPONDENCE RECEIVED IN LAW OFFICE	015
12/14/2020	TROA	I	TEAS RESPONSE TO OFFICE ACTION RECEIVED	014
06/12/2020	GNRN	O	NOTIFICATION OF NON-FINAL ACTION E-MAILED	013
06/12/2020	GNRT	O	NON-FINAL ACTION E-MAILED	012
06/12/2020	CNRT	R	NON-FINAL ACTION WRITTEN	011
05/18/2020	TEME	I	TEAS/EMAIL CORRESPONDENCE ENTERED	010
05/16/2020	CRFA	I	CORRESPONDENCE RECEIVED IN LAW OFFICE	009
05/16/2020	TROA	I	TEAS RESPONSE TO OFFICE ACTION RECEIVED	008
11/16/2019	GNRN	O	NOTIFICATION OF NON-FINAL ACTION E-MAILED	007
11/16/2019	GNRT	F	NON-FINAL ACTION E-MAILED	006
11/16/2019	CNRT	R	NON-FINAL ACTION WRITTEN	005
11/12/2019	DOCK	D	ASSIGNED TO EXAMINER	004
09/25/2019	MDSC	E	NOTICE OF DESIGN SEARCH CODE E-MAILED	003
09/24/2019	NWOS	I	NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM	002
09/20/2019	NWAP	I	NEW APPLICATION ENTERED IN TRAM	001

CURRENT CORRESPONDENCE INFORMATION
ATTORNEY	Cynthia Walden
CORRESPONDENCE ADDRESS	Cynthia Walden Fish & Richardson P.C. PO Box 1022 Minneapolis MN 55440-1022
DOMESTIC REPRESENTATIVE	NONE

PRIOR OWNER INFORMATION
PARTY TYPE	10-ORIGINAL APPLICANT
NAME	Elevar Therapeutics, Inc.
ADDRESS	2825 East Cottonwood Parkway, Suite 180 Salt Lake City, UT 84121
ENTITY	03-CORPORATION
CITIZENSHIP	Utah

ITU Unit Action

TULVEGIO RIVOCERANIB

Elevar Therapeutics, Inc.

ITU Unit Action

ITU Unit Action [image/jpeg]